NPI: 1154317964 · LAS VEGAS, NV 89119 · General Acute Care Hospital · NPI assigned 09/27/2005
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR, VP) |
| NPI Enumeration Date | 09/27/2005 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 111,371 | $1.82M |
| 2019 | 260,093 | $5.38M |
| 2020 | 201,149 | $4.22M |
| 2021 | 215,313 | $4.69M |
| 2022 | 193,102 | $4.58M |
| 2023 | 66,989 | $1.60M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 42,161 | 34,552 | $4.62M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 24,638 | 21,543 | $2.26M |
| G0378 | Hospital observation service, per hour | 18,145 | 13,423 | $2.13M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6,729 | 5,673 | $1.54M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 25,980 | 20,890 | $1.33M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5,228 | 4,466 | $820K |
| 70450 | Computed tomography, head or brain; without contrast material | 9,082 | 7,691 | $723K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,554 | 2,125 | $601K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 22,466 | 17,577 | $544K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 30,146 | 23,611 | $520K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,052 | 891 | $461K |
| 96361 | Intravenous infusion, hydration; each additional hour | 23,504 | 17,673 | $441K |
| 96375 | Therapeutic injection; each additional sequential IV push | 24,650 | 18,289 | $416K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 19,390 | 13,156 | $271K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,016 | 1,773 | $255K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6,725 | 5,967 | $228K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7,041 | 5,739 | $213K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,711 | 9,596 | $213K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,784 | 4,223 | $205K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 6,573 | 5,592 | $196K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 62,705 | 45,687 | $190K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 34,736 | 26,090 | $164K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,440 | 1,210 | $157K |
| 80053 | Comprehensive metabolic panel | 34,420 | 27,221 | $154K |
| 71045 | Radiologic examination, chest; single view | 24,239 | 19,810 | $148K |
| 0450 | Emergency room services | 3,717 | 3,271 | $144K |
| 84484 | 32,227 | 17,970 | $127K | |
| 72131 | 985 | 827 | $122K | |
| 96376 | 9,680 | 5,414 | $116K | |
| 36415 | Collection of venous blood by venipuncture | 74,739 | 49,088 | $103K |
| 80048 | Basic metabolic panel (calcium, ionized) | 31,707 | 23,056 | $101K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,739 | 1,462 | $99K |
| J2785 | Injection, regadenoson, 0.1 mg | 820 | 697 | $94K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2,327 | 1,036 | $94K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 959 | 907 | $87K |
| 83880 | 7,877 | 6,408 | $83K | |
| 76830 | Ultrasound, transvaginal | 1,196 | 1,005 | $82K |
| 84702 | 12,111 | 10,230 | $82K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,741 | 1,502 | $81K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1,050 | 888 | $79K |
| 93971 | 1,717 | 1,502 | $74K | |
| 71046 | Radiologic examination, chest; 2 views | 6,150 | 5,232 | $68K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2,033 | 1,640 | $66K |
| 70486 | 505 | 475 | $65K | |
| 93970 | 959 | 809 | $63K | |
| 76801 | 955 | 807 | $57K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,832 | 1,183 | $54K |
| 90715 | 1,305 | 1,194 | $53K | |
| 83690 | 18,118 | 14,673 | $51K | |
| 83605 | 11,564 | 8,609 | $46K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,053 | 1,870 | $46K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 16,517 | 11,168 | $40K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2,199 | 1,881 | $37K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,428 | 1,158 | $36K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,149 | 1,754 | $34K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,149 | 1,756 | $34K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,011 | 3,318 | $34K |
| 70496 | 104 | 90 | $33K | |
| 73564 | 1,774 | 1,575 | $31K | |
| 70498 | 137 | 116 | $31K | |
| 87040 | 6,692 | 3,564 | $30K | |
| 10060 | 423 | 391 | $29K | |
| 81001 | 22,174 | 18,354 | $29K | |
| 81025 | 10,651 | 8,877 | $28K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 8,843 | 7,375 | $28K |
| 85730 | 14,444 | 11,520 | $28K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 6,563 | 4,824 | $26K |
| 83735 | 11,751 | 7,829 | $25K | |
| 73630 | 1,708 | 1,538 | $25K | |
| 73130 | 1,356 | 1,221 | $24K | |
| 85610 | 17,878 | 14,045 | $22K | |
| 73610 | 1,288 | 1,147 | $21K | |
| 85379 | 5,317 | 4,544 | $21K | |
| 97162 | 875 | 627 | $18K | |
| 93017 | 1,075 | 910 | $18K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 177 | 143 | $18K |
| 73030 | 1,300 | 1,155 | $17K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 21,700 | 16,179 | $17K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,789 | 664 | $17K |
| 94664 | 2,723 | 1,427 | $17K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3,002 | 2,543 | $17K |
| 97535 | Self-care/home management training, each 15 minutes | 1,750 | 847 | $16K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,308 | 1,195 | $15K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,032 | 939 | $15K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 301 | 252 | $15K |
| 87186 | 4,271 | 2,992 | $15K | |
| 82550 | 5,655 | 4,506 | $14K | |
| 80061 | Lipid panel | 3,280 | 2,705 | $14K |
| 72100 | 998 | 850 | $14K | |
| 87641 | 1,677 | 1,359 | $13K | |
| 80076 | 4,018 | 3,277 | $13K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,747 | 959 | $13K |
| Z7502 | 350 | 316 | $13K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 109 | 85 | $12K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 2,344 | 1,832 | $12K |
| 96367 | 804 | 642 | $11K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7,393 | 6,472 | $11K |
| 73110 | 516 | 454 | $11K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,570 | 886 | $11K |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,968 | 2,417 | $11K |
| 82962 | 16,600 | 5,416 | $10K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,749 | 2,422 | $10K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 7,337 | 6,030 | $10K |
| 70491 | 63 | 52 | $10K | |
| 94644 | 440 | 367 | $9K | |
| 93880 | 153 | 121 | $9K | |
| J3490 | Unclassified drugs | 639 | 476 | $9K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4,089 | 3,327 | $9K |
| 93458 | 14 | 13 | $9K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 2,097 | 1,410 | $9K |
| 80074 | 483 | 396 | $8K | |
| 97166 | 403 | 298 | $8K | |
| 81003 | 9,606 | 8,057 | $8K | |
| J1644 | Injection, heparin sodium, per 1000 units | 5,467 | 2,578 | $7K |
| 85027 | 4,128 | 2,537 | $7K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 6,285 | 5,141 | $6K |
| J2358 | Injection, olanzapine, long-acting, 1 mg | 349 | 296 | $6K |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,931 | 944 | $6K |
| 71101 | 336 | 288 | $6K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 520 | 435 | $5K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 40 | 25 | $5K |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 162 | 140 | $5K |
| J1630 | Injection, haloperidol, up to 5 mg | 2,230 | 1,668 | $5K |
| 84439 | 1,347 | 1,133 | $5K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 245 | 189 | $5K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,324 | 2,724 | $4K |
| J2060 | Injection, lorazepam, 2 mg | 6,443 | 4,617 | $4K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 5,346 | 3,883 | $4K |
| 74022 | 171 | 143 | $4K | |
| 82803 | 729 | 552 | $4K | |
| 80069 | 2,055 | 1,118 | $4K | |
| 73502 | 248 | 213 | $4K | |
| 95816 | 34 | 27 | $3K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,767 | 2,933 | $3K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 66 | 62 | $3K |
| 86140 | 1,673 | 1,412 | $3K | |
| 84145 | 378 | 314 | $3K | |
| 82140 | 607 | 490 | $3K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,799 | 1,370 | $3K |
| 97116 | 490 | 248 | $3K | |
| 0270 | 505 | 305 | $3K | |
| 0250 | 206 | 116 | $3K | |
| 86900 | 2,234 | 1,891 | $3K | |
| 86901 | 2,234 | 1,891 | $3K | |
| 86850 | 1,433 | 1,195 | $2K | |
| 72040 | 145 | 117 | $2K | |
| 73590 | 161 | 153 | $2K | |
| J2704 | Injection, propofol, 10 mg | 3,349 | 2,717 | $2K |
| 84100 | 1,186 | 929 | $2K | |
| J1953 | Injection, levetiracetam, 10 mg | 181 | 149 | $2K |
| 87077 | 473 | 361 | $2K | |
| J3480 | Injection, potassium chloride, per 2 meq | 380 | 256 | $2K |
| 71250 | 31 | 25 | $2K | |
| 87205 | 1,188 | 911 | $2K | |
| 87210 | 806 | 653 | $2K | |
| 85652 | 1,507 | 1,247 | $2K | |
| J1940 | Injection, furosemide, up to 20 mg | 1,259 | 673 | $2K |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 52 | 42 | $2K |
| C9113 | Injection, pantoprazole sodium, per vial | 1,824 | 1,149 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,971 | 3,189 | $2K |
| J0780 | Injection, prochlorperazine, up to 10 mg | 339 | 286 | $1K |
| 96368 | 164 | 133 | $1K | |
| 90686 | 192 | 152 | $1K | |
| 82010 | 457 | 379 | $1K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,613 | 1,241 | $1K |
| 29125 | 62 | 54 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 19 | 16 | $1K |
| 87070 | 605 | 495 | $1K | |
| 97165 | 29 | 28 | $1K | |
| 87275 | 345 | 298 | $1K | |
| 84132 | 1,042 | 820 | $1K | |
| 72128 | 13 | 13 | $1K | |
| 99070 | 135 | 55 | $1K | |
| J0456 | Injection, azithromycin, 500 mg | 424 | 345 | $1K |
| G0008 | Administration of influenza virus vaccine | 194 | 153 | $999.30 |
| 74018 | 88 | 76 | $940.87 | |
| 87276 | 344 | 297 | $911.30 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 321 | 259 | $870.00 |
| 97161 | 37 | 29 | $861.53 | |
| 97163 | 31 | 27 | $778.17 | |
| C1781 | Mesh (implantable) | 28 | 26 | $756.00 |
| 73080 | 61 | 50 | $730.33 | |
| 76870 | 26 | 25 | $636.46 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 145 | 76 | $634.29 |
| J3360 | Injection, diazepam, up to 5 mg | 46 | 42 | $514.37 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 24 | 14 | $513.10 |
| J8540 | Dexamethasone, oral, 0.25 mg | 234 | 202 | $449.57 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,294 | 1,834 | $445.41 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 103 | 42 | $394.66 |
| 82150 | 134 | 122 | $393.82 | |
| 83615 | 157 | 136 | $386.61 | |
| 76775 | 16 | 13 | $378.87 | |
| 36600 | 78 | 65 | $371.79 | |
| 99152 | 97 | 76 | $275.01 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 68 | 51 | $268.38 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 271 | 251 | $266.22 |
| 82728 | 76 | 61 | $260.40 | |
| 87081 | 175 | 137 | $221.84 | |
| 82607 | 39 | 38 | $175.81 | |
| 82805 | 12 | 12 | $175.45 | |
| 73060 | 14 | 12 | $153.10 | |
| 87631 | 274 | 220 | $146.58 | |
| 73090 | 13 | 12 | $129.20 | |
| Z7610 | 14 | 12 | $127.90 | |
| A9270 | Non-covered item or service | 18,925 | 3,442 | $125.71 |
| 72170 | 14 | 12 | $107.82 | |
| A4217 | Sterile water/saline, 500 ml | 13 | 12 | $102.00 |
| C1769 | Guide wire | 601 | 459 | $87.59 |
| 85347 | 33 | 13 | $78.58 | |
| 85018 | 131 | 109 | $75.03 | |
| 86780 | 13 | 12 | $73.14 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 58 | 44 | $68.76 |
| 85014 | 97 | 82 | $57.11 | |
| 87184 | 15 | 15 | $51.81 | |
| 99000 | 14 | 12 | $50.82 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 111 | 77 | $45.27 |
| J1790 | Injection, droperidol, up to 5 mg | 33 | 33 | $42.57 |
| 83540 | 19 | 15 | $35.01 | |
| 83550 | 16 | 12 | $33.46 | |
| J2800 | Injection, methocarbamol, up to 10 ml | 24 | 24 | $26.67 |
| 87430 | 32 | 30 | $11.53 | |
| 99153 | Mod sedat endo service >5yrs | 39 | 28 | $2.50 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 118 | 91 | $0.01 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 132 | 102 | $0.01 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 36 | 17 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 83 | 68 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 709 | 547 | $0.00 |
| 0353U | 292 | 278 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 145 | 120 | $0.00 |
| C1729 | Catheter, drainage | 24 | 14 | $0.00 |